Consolidated Statement Of Income

Carna Biosciences, Inc. - Filing #7272198

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Consolidated statement of income
Statement of income
Net sales
542,056,000 JPY
636,235,000 JPY
636,235,000 JPY
JPY
636,235,000 JPY
JPY
1,625,889,000 JPY
1,625,889,000 JPY
JPY
1,468,204,000 JPY
707,650,000 JPY
918,239,000 JPY
Operating expenses
Operating expenses - general
Depreciation
2,918,000 JPY
2,736,000 JPY
Operating expenses
Selling, general and administrative expenses
2,438,338,000 JPY
2,541,797,000 JPY
2,567,574,000 JPY
2,464,484,000 JPY
Operating expenses
Cost of sales
170,542,000 JPY
170,542,000 JPY
175,293,000 JPY
174,122,000 JPY
Ordinary profit (loss)
-2,072,150,000 JPY
-2,080,739,000 JPY
-1,126,283,000 JPY
-1,176,623,000 JPY
Net sales
Gross profit (loss)
371,513,000 JPY
465,692,000 JPY
1,450,595,000 JPY
1,294,082,000 JPY
Operating profit (loss)
-2,066,824,000 JPY
-34,159,000 JPY
-2,076,104,000 JPY
-2,041,945,000 JPY
-2,076,104,000 JPY
JPY
-1,116,978,000 JPY
-1,116,978,000 JPY
JPY
-1,170,402,000 JPY
-1,342,546,000 JPY
225,567,000 JPY
Operating expenses
Research and development expenses
1,886,906,000 JPY
1,886,906,000 JPY
1,903,859,000 JPY
1,903,859,000 JPY
General and administrative expenses
Non-operating income
43,406,000 JPY
44,097,000 JPY
756,000 JPY
3,126,000 JPY
Dividend income
442,000 JPY
442,000 JPY
426,000 JPY
426,000 JPY
Interest income
14,407,000 JPY
14,504,000 JPY
170,000 JPY
81,000 JPY
Cost of sales
Non-operating income
Other
2,440,000 JPY
2,703,000 JPY
159,000 JPY
159,000 JPY
Selling, general and administrative expenses
Non-operating expenses
Interest expenses
2,958,000 JPY
2,958,000 JPY
3,451,000 JPY
3,428,000 JPY
Other
JPY
JPY
0 JPY
23,000 JPY
Non-operating expenses
48,732,000 JPY
48,732,000 JPY
10,061,000 JPY
9,347,000 JPY
Share issuance costs
45,377,000 JPY
45,377,000 JPY
5,219,000 JPY
5,219,000 JPY
Extraordinary losses
92,569,000 JPY
93,237,000 JPY
4,562,000 JPY
4,562,000 JPY
Impairment losses
15,654,000 JPY
JPY
92,569,000 JPY
64,405,000 JPY
93,237,000 JPY
13,176,000 JPY
77,582,000 JPY
JPY
4,562,000 JPY
JPY
4,562,000 JPY
4,562,000 JPY
4,562,000 JPY
JPY
Profit (loss) before income taxes
-2,164,720,000 JPY
-2,173,976,000 JPY
-1,130,846,000 JPY
-1,181,186,000 JPY
Gross profit
Income taxes - current
3,880,000 JPY
4,704,000 JPY
22,161,000 JPY
3,880,000 JPY
Extraordinary losses
Income taxes - deferred
-104,000 JPY
-104,000 JPY
-113,000 JPY
-113,000 JPY
Income taxes
3,775,000 JPY
4,599,000 JPY
22,048,000 JPY
3,766,000 JPY
Profit (loss)
-2,168,495,000 JPY
-2,168,495,000 JPY
-2,168,495,000 JPY
-2,178,576,000 JPY
-2,168,495,000 JPY
-1,152,895,000 JPY
-1,184,953,000 JPY
-1,184,953,000 JPY
-1,184,953,000 JPY
-1,184,953,000 JPY
Profit (loss) attributable to owners of parent
-2,178,576,000 JPY
-2,178,576,000 JPY
-2,178,576,000 JPY
-1,152,895,000 JPY
-1,152,895,000 JPY
-1,152,895,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-707,000 JPY
-349,000 JPY
Deferred gains or losses on hedges
JPY
-615,000 JPY
Foreign currency translation adjustment
34,637,000 JPY
18,483,000 JPY
Other comprehensive income
33,929,000 JPY
17,518,000 JPY
Profit attributable to
Comprehensive income
-2,144,646,000 JPY
-1,135,377,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-2,144,646,000 JPY
-1,135,377,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.